Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
10/2007
10/18/2007WO2004027075A3 Chemoenzymatic methods for the synthesis of statins and stain intermediates
10/18/2007WO2002061054A3 Method for increasing the virus propagation and the virus yield in cell cultures by blocking the activation of rnasel
10/18/2007US20070245432 Plants Having Improved Growth Characteristics and Method for Making the Same
10/18/2007US20070245428 Bacillus thuringiensis cry gene and protein
10/18/2007US20070245427 Pesticidal polypeptide for protecting plants against insects
10/18/2007US20070245425 Soybean Isopentenyl Transferase Genes and Methods of Use
10/18/2007US20070244314 Method For Extracting Nucleic Acid And Nucleic Acid-Extracting Apparatus
10/18/2007US20070244313 Method for detecting base mutation
10/18/2007US20070244312 siRNA targeting phosphoinositide-3-kinase, class 2, alpha polypeptide (PIK3C2A)
10/18/2007US20070244311 siRNA targeting coatomer protein complex, subunit beta 2 (CPOB2)
10/18/2007US20070244298 Polynucleotide encoding a variant polypeptide of wild-type DsRed or DsRed.T4, a tetrameric variant that has reduced oligomerization relative wild-type DsRed and a fluorescence spectra similar to the fluorescence spectra of the wild-type DsRed
10/18/2007US20070244061 Compositions for Diagnosis and Therapy of Diseases Associated with Aberrant Expression of Futrins (R-Spondisn) and/or Wnt
10/18/2007US20070244047 Albumin fusion proteins
10/18/2007US20070244043 Recombinant E-selectin made in insect cells
10/18/2007US20070244035 Novel co-modulators of nuclear receptors and methods of detecting and treating steroid hormone-dependent diseases using same
10/18/2007US20070244032 Cancer Cell Targeting Gene Delivery Method
10/18/2007US20070244031 Methods and Compositions for Homozygous Gene Inactivation Using Collections of Pre-Defined Nucleotide Sequences Complementary Chromosomal Transcripts
10/18/2007US20070244021 Polypeptides with perhydrolase activity
10/18/2007US20070244020 Enzyme fusion proteins and their use
10/18/2007US20070243617 Modular genomes for synthetic biology and metabolic engineering
10/18/2007US20070243614 Pesticidal polypeptides; to protect a plant from an insect pest
10/18/2007US20070243611 WT1 interacting protein WTIP
10/18/2007US20070243606 Ribonucleases and methods of them recombinantly
10/18/2007US20070243605 Ribonucleases and methods of making them recombinantly
10/18/2007US20070243604 Marker for Selecting Transformant with The Use of Lethal Gene
10/18/2007US20070243595 Modified enzymes, methods to produce modified enzymes and uses thereof
10/18/2007US20070243594 Oxidoreductase from Pichia Capsulata
10/18/2007US20070243589 Antibodies against human IL-22 and uses therefor
10/18/2007US20070243588 Blood coagulation factor; nucleotide sequence encodes polypeptide; amino acid sequence differs in 1-15 amino acid residues and comprises an introduced in vivo N-glycosylation site; substitution V253N; coagulation related disorders
10/18/2007US20070243587 Using a reverse genetic engineering platform to produce protein vaccines and protein vaccine of avian influenza virus
10/18/2007US20070243586 Novel organic anion transport proteins
10/18/2007US20070243585 Using expression vector comprising bacterial nucleotide sequences to prepare polypeptides for use in diagnosis, prevention and treatment of microorganismal infection
10/18/2007US20070243583 comprising an N-terminal domain derived from E. coli FkpA that allows for dimerization and provides a substrate binding region, and a C-terminal thioredoxin domain derived from E. coli DsbA
10/18/2007US20070243582 Process for Producing Protein a-Like Protein with Use of Brevibacillus Genus Bacterium
10/18/2007US20070243581 Process for Producing Dipeptides
10/18/2007US20070243580 BASB019 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
10/18/2007US20070243569 producing a kinase/phosphatase inducible domain by replacing a structurally significant glutamic acid or aspartic acid residue in an EF hand domain with a replacement serine or threonine residue; producing a phosphorylation-dependent protein domain; Alzheimer's and heart disease
10/18/2007US20070243566 Amino acid residue insertion between an amino acid positions corresponding to positions 428 and 429 of the s-GDH wild-type sequence known from Acinetobacter calcoaceticus; method for measurement of glucose, especially by a tests strip device or with a biosensor
10/18/2007US20070243555 Method of Detecting the Cystic Fibrosis Transmembrane Conductance Regulator (Cftr) at Cell Exterior
10/18/2007US20070243550 Molecular Detection and Quantification of Enterococci
10/18/2007US20070243544 Compositions for use in identification of bacteria
10/18/2007US20070243543 Method for Isolation of Transcription Termination Sequences
10/18/2007US20070243542 Use of a weakly basic polymer for the capture and selective release of the captured nucleic acids from the polymer; Upon binding DNA the polymer becomes insoluble
10/18/2007US20070243541 Compositions and methods for generating antigen-binding units
10/18/2007US20070243539 Genetic variants of human inositol polyphosphate-4-phosphatase, type i (inpp4a) useful for prediction and therapy of immunological disorder
10/18/2007US20070243535 Methods for increasing accuracy of nucleic acid sequencing
10/18/2007US20070243533 Products and methods of organism identification in nutritional supplements
10/18/2007US20070243531 Methods of Diagnosing Colorectal Cancer and Reagents Therefor
10/18/2007US20070243530 Nucleic Acid Probes and Broad-Range Primers from Regions in Dna Directed Rna Polymerase Subunit B Genes, and Methods in Which They are Used
10/18/2007US20070243526 AAV capsid library and AAV capsid proteins
10/18/2007US20070243524 sequences from the Core/E1 region of HCV type 3; detection of HCV infection
10/18/2007US20070243303 Methods and Means for Regulating Gene Expression
10/18/2007US20070243242 Compositions for treating hearing loss and methods of use thereof
10/18/2007US20070243209 Compositions and methods for prevention and treatment of fungal diseases
10/18/2007US20070243208 Novel chimeric protein for prevention and treatment of hiv infection
10/18/2007US20070243207 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
10/18/2007US20070243205 Polypeptides for Inducing a Protective Immune Response Against Staphylococcus Aureus
10/18/2007US20070243204 Helicobacter pylori proteins useful for vaccines and diagnostics
10/18/2007US20070243203 HIV polypeptide and polynucleotide fusions of Gag, Pol and Nef; AIDS; purifying the fusion polypeptide; carboxyamidation
10/18/2007US20070243202 Tumor necrosis factor receptor-associated factors
10/18/2007US20070243194 Anti-IGF-1R antibodies and uses thereof
10/18/2007US20070243191 Anti-hyperproliferative therapies targeting hdgf
10/18/2007US20070243181 Irak1c Splice Variant And Its Use
10/18/2007US20070243176 Human genes and gene expression products
10/18/2007DE10045123B4 Das C. albicans TEC1 GEN(CaTEC1) und das kodierte Tec1p Protein The C. albicans TEC1 GEN (CaTEC1) and the encoded protein Tec1p
10/18/2007DE10006590B4 Verwendung funktionalisierter Membranen bzw. Matrizes zur Aufreinigung von Nukleinsäuren sowie entsprechende Verfahren Use of functionalized membranes and matrices for purification of nucleic acids and corresponding methods
10/18/2007CA2649182A1 Methods and compositions related to adenoassociated virus-phage particles
10/18/2007CA2648585A1 Stabilized immune modulatory rna (simra) compounds for tlr7 and tlr8
10/18/2007CA2616859A1 Compositions and methods for production of immunoglobulins
10/17/2007EP1844068A1 Molecules and chimeric molecules thereof
10/17/2007EP1843785A2 Polypeptides for inducing a protective immune response against staphylococcus aureus
10/17/2007EP1692312A4 Short cycle methods for sequencing polynucleotides
10/17/2007EP1567662A4 Caged sensors, regulators and compounds and uses thereof
10/17/2007EP1107661B1 Plant fatty acid desaturase promoters
10/17/2007EP1105502B1 Maize cellulose synthases and uses thereof
10/17/2007EP0862442A4 Methods for diagnosis and treatment of bloom's syndrome
10/17/2007CN101056883A Amplification blocker for imbedibility nucleic acid (ina) containing imbedibility pseudo nucleic acid (IPN)
10/17/2007CN101054580A Imitation miRNA sequence and preparation method thereof
10/17/2007CN101053573A Compositions and methods based on VEGF antisense oligonucleotides
10/17/2007CN100343393C Central airway administration for systemic delivery of therapeutics
10/17/2007CN100343280C CUDR as biomarker for cancer progression and therapeutic response
10/16/2007US7282581 Complexing with label; immobilization; genetic engineering
10/16/2007US7282580 Protein molecule useful for inhibition of anthrax toxin
10/16/2007US7282579 Serine protease BSSP6
10/16/2007US7282578 Having at least one intron sequence; constructs and host cells; expression product and antibodies obtainable by immunization of an animal therewith, as well as the use of antibodies in screening methods for the identification of tumors
10/16/2007US7282577 Nucleotide sequences coding hemolytic protein for use tool in treatment of jelly fish stings
10/16/2007US7282576 Coactivators in the diagnosis and treatment of breast cancer
10/16/2007US7282570 Nucleotide sequences for use in the treatment and diagnosis of immunological and inflammatory disorders
10/16/2007US7282562 Invention is based on identification of proteins (including agonist and antagonist antibodies) which either stimulate or inhibit immune response in mammals; immune related diseases can be treated by suppressing or enhancing immune response
10/16/2007US7282561 PRO16090 polypeptides
10/16/2007US7282560 PRO 4326 polypeptides
10/16/2007US7282559 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2007US7282558 PRO4329 polypeptide
10/16/2007US7282556 Polynucleotides and polypeptides relating to the modulation of SIRPα-CD47
10/16/2007US7282489 Delivering plasmid vector encoding HERG (A561V) (human ether-a-go-go related gene) protein to cells afflicted with re-entrant atrial flutter mediated cardiac arrhythmia
10/16/2007US7282361 Treating mammalian tissue with a lysis buffer of proteinase K to obtain a lysate, binding genomic DNA to magnetic particles in the presence of the lysate, and disassociating the DNA from the magnetic particles
10/16/2007US7282360 Human protein kinase, phosphatase, and protease family members and uses thereof
10/16/2007US7282357 Method for the production by fermentation of sulphur-containing fine chemicals (metF)
10/16/2007US7282355 Nucleic acid detection method
10/16/2007US7282353 Protein isolation